Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
about
A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers.Buprenorphine: a unique drug with complex pharmacologyOpioid receptor trafficking and interaction in nociceptorsAntibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and functionOpioid receptor heteromers in analgesiaCurrent research on opioid receptor function.Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cellsActivity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR geneDifferential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against various Gi-protein alpha subunitsEmergence of functional spinal delta opioid receptors after chronic ethanol exposureContribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes.How to design an opioid drug that causes reduced tolerance and dependence.Alterations of CXCR4 function in μ-opioid receptor-deficient glia.The μ-opioid receptor variant N190K is unresponsive to peptide agonists yet can be rescued by small-molecule drugs.Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.Recent advances on the δ opioid receptor: from trafficking to function.Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout miceIn vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance.Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.A subanalgesic dose of morphine eliminates nalbuphine anti-analgesia in postoperative painTruncated mu opioid GPCR variant involvement in opioid-dependent and opioid-independent pain modulatory systems within the CNS.Pharmacological traits of delta opioid receptors: pitfalls or opportunities?Abolished thermal and mechanical antinociception but retained visceral chemical antinociception induced by butorphanol in mu-opioid receptor knockout miceModulation between high- and low-frequency transcutaneous electric nerve stimulation delays the development of analgesic tolerance in arthritic rats.Opiate-agonist induced taste aversion learning in the Fischer 344 and Lewis inbred rat strains: evidence for differential mu opioid receptor activation.Spinal μ and δ opioids inhibit both thermal and mechanical pain in rats.The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake.A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesiaPharmacological Profiles of Oligomerized μ-Opioid Receptors.Interaction and regulatory functions of μ- and δ-opioid receptors in nociceptive afferent neurons.Src promotes delta opioid receptor (DOR) desensitization by interfering with receptor recycling.In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential.Sensitivity to μ-opioid receptor-mediated anti-nociception is determined by cross-regulation between μ- and δ-opioid receptors at supraspinal level.Role of mu-opioid receptor in modulation of preproenkephalin mRNA expression and opioid and dopamine receptor binding in methamphetamine-sensitized miceMusic Therapy and Social Skills in Autism: Underlying Biological Mechanisms.
P2860
Q24530081-4AA0E02C-7F52-4FEF-959A-4B6EE78AFBD4Q24642980-4FE12DEC-9E5F-4F4B-B297-DE06C18230C3Q26822251-B37F3557-E89E-4AD8-BA12-7085DA125C10Q26992192-3330F857-A7C6-4487-B394-53C42B5E6F1AQ27004306-29FB905B-712A-41E4-A695-DDC8B7F8FB80Q27693220-722BA6E0-924F-49B7-A013-08C149832EE3Q28344890-390369DC-A3CC-4C96-B8D7-665A7254744DQ28361204-14087C85-85B2-4BD4-BF95-FDF7CD77D4C4Q28364877-8369B0D0-A7AE-48EE-B929-8EF5B8B3B4B6Q33863121-33FC806E-59A1-4C9E-A1AA-C528543C84E1Q33863139-E1480F16-ED20-4E0E-8825-75D13A1BCB6BQ34144947-36D98E96-535F-4F0C-8776-93813D45014CQ34209473-2D2AA76A-3A75-47BE-BCD4-3A92A75C2397Q34309916-68B8FF63-EF36-4C61-A69E-651B2442252EQ34939624-32C3FC9B-658C-41A2-A836-BAEB5C77F862Q34939664-616B8BEA-F1ED-44E8-9223-8E8CC56C8546Q35028449-01452EBF-7D36-4DC9-B1A0-F66E972E06C2Q36358677-0B2DA13B-7F69-41B9-9AF2-7C8B0034A5B7Q36372689-3DF89DDC-3C7F-4354-8612-12145AE2121AQ36625540-6F22743B-13E8-438C-96A4-4D1CDCB9337EQ36770675-B3A004A0-7452-444A-9E78-2120579EFA66Q36920342-74D32BB7-EE5F-485C-AC02-89B7A3125E7FQ37162582-24519C39-A6F9-490A-8B85-C7B65337B340Q37347915-F8648E4D-2C77-425C-85FF-47D8F77E485BQ37364459-BC838730-2B3A-481C-AA3F-5D795F5B8123Q37374021-0C4F524B-C39B-40FC-BACC-DDB2C371956EQ37376376-876B276D-4A36-4CE0-8340-31E5D8D331C2Q37416417-6A4D7336-3369-41E5-94AF-973850B35F7CQ37679197-5518D4B4-E426-4BDB-A723-CFA67FB9E312Q37998861-E98F88E3-E44A-46DB-9B73-920E5C26490EQ39998920-BDA6C4B2-4E5D-4040-BC89-85D613F9D820Q42067858-FF308E5F-2CEC-46F5-AFBF-95FA15B2B2FCQ42269176-83BB9640-791F-409E-B077-797667B4659EQ42530710-9B9244B3-2761-409D-B731-528901282AF1Q55040679-616BB417-0870-4760-BCB0-DAAD4066DF83
P2860
Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Activity of the delta-opioid r ...... mice lacking the mu-receptor.
@en
Activity of the delta-opioid r ...... mice lacking the mu-receptor.
@nl
type
label
Activity of the delta-opioid r ...... mice lacking the mu-receptor.
@en
Activity of the delta-opioid r ...... mice lacking the mu-receptor.
@nl
prefLabel
Activity of the delta-opioid r ...... mice lacking the mu-receptor.
@en
Activity of the delta-opioid r ...... mice lacking the mu-receptor.
@nl
P2093
P1476
Activity of the delta-opioid r ...... n mice lacking the mu-receptor
@en
P2093
B L Kieffer
B P Roques
C Severini
E Boudinot
H W Matthes
J L Vonesch
M Denavit-Saubié
P304
P356
10.1523/JNEUROSCI.18-18-07285.1998
P407
P577
1998-09-01T00:00:00Z